InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
ReviveThomas Free
01/12/24 10:22 AM
profile icon
ANTI-BAGHOLDER PremiumMember
01/27/23 10:13 AM
profile icon
DarkPool Free
01/25/23 8:41 AM
profile icon
GorillaDaddy Free
01/07/22 12:10 AM
profile icon
willlbone Free
01/06/22 3:49 PM
profile icon
GorillaDaddy Free
12/16/21 2:21 PM
profile icon
Juschilln Free
12/16/21 2:19 PM
profile icon
GorillaDaddy Free
12/16/21 2:16 PM
profile icon
GorillaDaddy Free
12/15/21 8:30 PM
profile icon
Time To Roll Free
10/24/21 9:24 AM
profile icon
GorillaDaddy Free
10/15/21 7:21 PM
profile icon
GorillaDaddy Free
07/06/21 6:52 PM
profile icon
GorillaDaddy Free
06/03/21 11:04 AM
profile icon
GorillaDaddy Free
06/03/21 12:17 AM
profile icon
monique14 Free
06/02/21 6:02 PM
profile icon
T695 Free
05/25/21 4:53 PM
profile icon
MACDaddy Free
05/17/21 12:40 PM
profile icon
Mama_cass Free
05/13/21 8:18 AM
profile icon
GorillaDaddy Free
05/08/21 12:11 PM
profile icon
cnote420 Free
05/06/21 4:18 PM
profile icon
Always wondering Free
05/05/21 4:33 PM
profile icon
Juschilln Free
05/05/21 4:31 PM
profile icon
Juschilln Free
05/05/21 2:42 PM
profile icon
Renee PremiumMember
05/04/21 8:46 AM
profile icon
DarkPool Free
04/29/21 10:02 AM
profile icon
DarkPool Free
04/28/21 10:05 AM
profile icon
DarkPool Free
04/28/21 9:52 AM
profile icon
DarkPool Free
04/28/21 9:40 AM
profile icon
DarkPool Free
04/26/21 3:08 PM
profile icon
DarkPool Free
04/26/21 12:32 PM
profile icon
DarkPool Free
04/26/21 10:33 AM
profile icon
DarkPool Free
04/26/21 10:25 AM

Braxia Scientific Corp. (BRAXF) RSS Feed

Followers
38
Posters
83
Posts (Today)
0
Posts (Total)
662
Created
03/02/20
Type
Free
Moderators
      



 
Outstanding Shares
177,290,212
11/02/2020
Restricted
53,146,422
11/02/2020
Unrestricted
124,143,790
11/02/2020
Champignon Brands Inc.
 
Champignon Brand Inc. is a research-driven Company specializing in Mushroom Health Supplements that promote Holistic Health and Wellness.
---------------------------------------------------------------------------------------------------------------------------
The Canadian based company dedicated to the distribution of artisanal, medical mushrooms and associated CPGs.
------------------------------------------------------------------------------------------------------------------------------
The Champignon team believes that we enhance the health and wellness of Millions of consumers through the distribution of their premium, mushroom-infused suite of products.
-----------------------------------------------------------------------------------------------------------------------------
Champignon Brands Inc is a member of The AMerican Mushroom Institue (AMI). The Institue is a national voluntary trade association representing the growers, processors and marketers of the cultivated mushroom in the United States and the industry worldwide. Membership is available to any person interested in the mushroom industry.
Categories of membership are grower, associate, professional and retiree.
 

100% Intellectual Property Ownership

Patents are the lifeblood of the biotech industry. Biotechnology is one of the most research-intensive industries, with companies in the sector typically investing between 40% and 50% of their revenues in research and development, compared to 13% in pharmaceuticals and 5% in the chemical industry. In many cases, IP rights can actually be the final product.

That's why Champignon Brands' ( SHRM ; SHRMF ) already impressive cache of pharmaceutical patents gives it a leg up in the competitive rush to claim market share in the nascent Psilocybin industry.

Normally, when you do clinical trials, the ideal is to own the resulting IP. Champignon is partnering with the University of Miami and Miller School of Medicine in its research work but will own 100% of the intellectual property, drug discovery, and resultant data.

Its Psilocybin Patent Portfolio will greatly help the company in the commercialization of GMO and vegan certified rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. Even better: It can license its patented formulations to other companies as it deems fit.
 

Champignon Brands Provides Update on Continuous Disclosure Review

Canada NewsWire

VANCOUVER, BC, Oct. 29, 2020

VANCOUVER, BC, Oct. 29, 2020 /CNW/ - Champignon Brands Inc. ("Champignon" or the "Company") (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) continues to work diligently with the British Columbia Securities Commission (the "Commission") to address the ongoing continuous disclosure review and to coordinate the revocation of the existing cease trade order. The Company will provide guidance on definitive timing for revocation as soon as possible.

The Company has submitted all requested documentation to the Commission in connection with the review of financial statements of AltMed Capital Corp. ("AltMed") for the period ended June 30, 2020, and subject to review by the Commission expects to move forward with the finalization and public filing of these statements in short order. 

Continuous Disclosure Review History

On June 19, 2020, the Company was notified by the Commission that it would be subject to a continuous disclosure review. Such reviews are conducted by the Commission for the purposes of ensuring compliance with the continuous disclosure obligations imposed by applicable Canadian securities laws. In the case of the Company, this review relates to the Company's disclosure obligations since it became a reporting issuer on February 6, 2020 and includes a review of the disclosure surrounding acquisitions completed by the Company since that time.

In connection with the review, on June 19, 2020, the Commission issued a cease trade order suspending trading in the securities of the Company pending the filing of Business Acquisition Reports in connection with the acquisitions of Artisan Growers Ltd., Novo Formulations Ltd. and Tassili Life Sciences Corp. As a result of the cease trade order, trading in the common shares of the Company was suspended on the Canadian Securities Exchange.

The Business Acquisition Reports were filed by the Company on July 21, 2020, during which time the Company continued to work with the Commission to address comments received in the course of the disclosure review. As a result of the filing of the Business Acquisition Reports, on August 26, 2020, the Commission revoked the cease trade order previously issued on June 19, 2020. Concurrently with the revocation, the Commission issued a replacement cease trade order (the "Replacement Order"), pending the filing of a revised material change report (the "Material Change Report") in connection with the acquisition by the Company of AltMed.

Prior to the finalization of a revised Material Change Report, the Company is required to finalize the accounting treatment for the acquisition of AltMed, which includes compiling the financial statements of AltMed for the six-month period ended June 30, 2020 to meet disclosure requirements.

On October 27, 2020, the Commission issued an additional cease trade order pending the filing of the interim financial statements of the Company for the period ended June 30, 2020 (the "October Order").

The October Order is not expected to affect the review process or timing for the resumption of trading of the common shares of the Company as the reports required to be filed to satisfy the Replacement Order will address the outstanding items in the October Order. 

For further clarity, the Company anticipates that the Replacement Order and the October Order will be revoked at the same time.  The Company is working diligently with the Commission to ensure that the revocation of both the Replacement Order and October Order occurs as soon as possible.

Dr. Roger McIntyre
Chief Executive Officer
E: info@champignonbrands.com

FOR INVESTOR INQUIRIES:

Champignon Brands | Storyboard Communications
Investor Relations, Toronto, Canada
Investor Line:  +1 (833) 375-9995 x611
E: champignonbrands@storyboardcommunications.com

 



 
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
BRAXF Latest News
  • No Recent News Available for this company!
Most Liked Posts
(Last 30 Days)
New Post